{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:23:09Z","timestamp":1707524589393},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,31]]},"DOI":"10.7759\/cureus.25530","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T15:00:23Z","timestamp":1654009223000},"source":"Crossref","is-referenced-by-count":0,"title":["Challenges of Treating an Acute Hepatitis C Virus Infection With Concurrent Seizure Treatment in a Free Clinic"],"prefix":"10.7759","author":[{"given":"Nicholas","family":"Blackmond","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua D","family":"Kanke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiffany","family":"Loh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond","family":"Weitzman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S172512","article-title":"Glecaprevir\/pibrentasvir for the treatment of chronic hepatitis C: design, development, and place in therapy","volume":"13","author":"Cotter TG","year":"2019","unstructured":"Cotter TG, Jensen DM. Glecaprevir\/pibrentasvir for the treatment of chronic hepatitis C: design, development, and place in therapy. Drug Des Devel Ther. 2019, 13:2565-77. 10.2147\/DDDT.S172512","journal-title":"Drug Des Devel Ther"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0168-8278(03)00008-4","article-title":"Management of hepatitis C","volume":"38","author":"Alberti A","year":"2003","unstructured":"Alberti A, Benvegn\u00f9 L. Management of hepatitis C. J Hepatol. 2003, 38:S104-18. 10.1016\/s0168-8278(03)00008-4","journal-title":"J Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1177\/0897190020977762","article-title":"When coadministration cannot be avoided: real world experience of direct acting antivirals for the treatment of hepatitis C virus infection in patients on first generation anticonvulsants","author":"Natali KM","year":"2020","unstructured":"Natali KM, Jimenez HR, Slim J. When coadministration cannot be avoided: real world experience of direct acting antivirals for the treatment of hepatitis C virus infection in patients on first generation anticonvulsants. J Pharm Pract. 2020, 897190020977762. 10.1177\/0897190020977762","journal-title":"J Pharm Pract"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1177\/003335491412900213","article-title":"Hepatitis C seroprevalence among prison inmates since 2001: still high but declining","volume":"129","author":"Varan AK","year":"2014","unstructured":"Varan AK, Mercer DW, Stein MS, Spaulding AC. Hepatitis C seroprevalence among prison inmates since 2001: still high but declining. Public Health Rep. 2014, 129:187-95. 10.1177\/003335491412900213","journal-title":"Public Health Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30297","article-title":"Estimating prevalence of hepatitis C virus infection in the United States, 2013-2016","volume":"69","author":"Hofmeister MG","year":"2019","unstructured":"Hofmeister MG, Rosenthal EM, Barker LK, et al.. Estimating prevalence of hepatitis C virus infection in the United States, 2013-2016. Hepatology. 2019, 69:1020-31. 10.1002\/hep.30297","journal-title":"Hepatology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2016.0296","article-title":"New hepatitis C drugs are very costly and unavailable to many state prisoners","volume":"35","author":"Beckman AL","year":"2016","unstructured":"Beckman AL, Bilinski A, Boyko R, et al.. New hepatitis C drugs are very costly and unavailable to many state prisoners. Health Aff (Millwood). 2016, 35:1893-901. 10.1377\/hlthaff.2016.0296","journal-title":"Health Aff (Millwood)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s11524-017-0174-x","article-title":"Neighborhood inequalities in hepatitis C mortality: spatial and temporal patterns and associated factors","volume":"94","author":"Ford MM","year":"2017","unstructured":"Ford MM, Desai PS, Maduro G, Laraque F. Neighborhood inequalities in hepatitis C mortality: spatial and temporal patterns and associated factors. J Urban Health. 2017, 94:746-55. 10.1007\/s11524-017-0174-x","journal-title":"J Urban Health"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1108\/IJPH-04-2016-0010","article-title":"The association of recent incarceration and health outcomes among HIV-infected adults receiving care in the United States","volume":"12","author":"Nasrullah M","year":"2016","unstructured":"Nasrullah M, Frazier E, Fagan J, Hardnett F, Skarbinski J. The association of recent incarceration and health outcomes among HIV-infected adults receiving care in the United States. Int J Prison Health. 2016, 12:135-44. 10.1108\/IJPH-04-2016-0010","journal-title":"Int J Prison Health"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1177\/2381468318760298","article-title":"Access is necessary but not sufficient: factors influencing delay and avoidance of health care services","volume":"3","author":"Smith KT","year":"2018","unstructured":"Smith KT, Monti D, Mir N, Peters E, Tipirneni R, Politi MC. Access is necessary but not sufficient: factors influencing delay and avoidance of health care services. MDM Policy Pract. 2018, 3:2381468318760298. 10.1177\/2381468318760298","journal-title":"MDM Policy Pract"},{"key":"ref10","unstructured":"Social determinants of health. (2022). Accessed. May 14, 2022: https:\/\/www.who.int\/health-topics\/social-determinants-of-health."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/99675-challenges-of-treating-an-acute-hepatitis-c-virus-infection-with-concurrent-seizure-treatment-in-a-free-clinic","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:36:20Z","timestamp":1707507380000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/99675-challenges-of-treating-an-acute-hepatitis-c-virus-infection-with-concurrent-seizure-treatment-in-a-free-clinic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,31]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.25530","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,31]]}}}